Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for anesthesia induction in elderly patients with hypertension
ChiCTR2100042474Phase 4Not yet recruiting
- Sponsor
- Foshan Fosun Chancheng Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam and propofol in hypertension (HTN) (2 arms), sponsored by Foshan Fosun Chancheng Hospital. Primary endpoints: Percentage of successful anesthesia induction and Incidence of bradycardia. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2100042474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042474.